Expanded access programs are pathways for patients with serious or life-threatening diseases to access drugs in development outside of clinical trials when there are no other treatment options available. These programs are also known by other names, such as Compassionate Use, Early Access Programs, Managed Access Programs and Named Patient Programs. They are primarily driven by physicians on behalf of their patients.
myTomorrows Team
15 Dec 2025
4 mins read
Daniël Groeneweg
27 Nov 2025
8 mins read
Andrea Enguita
18 Nov 2025
21 mins read
Adrianne Rivard
14 Nov 2025
10 mins read
Michel van Harten
11 Nov 2025
7 mins read
Dennis Akkaya
10 Oct 2025
12 mins read
Michel van Harten
10 Oct 2025
2 mins read
Dennis Akkaya
18 Sep 2025
10 mins read
Andrea Enguita
13 Aug 2025
15 mins read
John Massarelli
7 Aug 2025
10 mins read